Open-label, Single-group, Multicentre, Phase III Study to Confirm the Efficacy and Safety of IP-TN When Administered for 2 Weeks to Patients With Low Back Pain, Scapulohumeral Periarthritis, or Cervico-omo-brachial Syndrome Associated With Muscle Strain
Phase of Trial: Phase III
Latest Information Update: 29 Nov 2016
At a glance
- Drugs Loxoprofen/methocarbamol (Primary)
- Indications Pain
- Focus Adverse reactions
- Sponsors Boehringer Ingelheim
- 24 Nov 2016 Status changed from recruiting to completed.
- 03 Aug 2016 Status changed from not yet recruiting to recruiting.
- 20 Jul 2016 New trial record